Radnostix (INIS) Cash & Equivalents (2010 - 2026)
Radnostix (INIS) posted Cash & Equivalents of $1.2 million for Q2 2026, down 35.7% from $1.86 million a year earlier and down 11.2% from the prior quarter.
Powered by 
Analysis
Radnostix (INIS) Cash & Equivalents (2010 - 2026) Analysis & Trends
At the end of FY2025, Radnostix's Cash & Equivalents came in at $1.7 million, down 12.9% from FY2024.
- Annual Cash & Equivalents shows a five-year compound annual growth rate of 8.8% (FY2020 to FY2025).
- In prior years, Radnostix's Cash & Equivalents was $1.95 million in FY2024 (-27.6%), $2.69 million in FY2023 (+13.1%), $2.38 million in FY2022 (+400.3%) and $474,851 in FY2021 (-57.3%).
- The Q2 2026 figure stands as the lowest quarterly Cash & Equivalents since Q4 2021.
- On a year-over-year basis, Cash & Equivalents has declined in each of the last ten quarters, with an average decline of 23.6% over the last eight quarters.
- The strongest year-over-year quarter for Cash & Equivalents in the past five years was Q1 2022, with growth of 657.2%; the weakest was Q4 2021, with a decline of 57.3%.
- According to Business Quant data, Cash & Equivalents for the three prior quarters was $1.35 million (Q1 2026), $1.7 million (Q4 2025) and $1.65 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,261.99 Bn | 1,235.61 Bn | 20.46 Bn | 4.89 Bn |
| 2 | Johnson & Johnson | 678.93 Bn | 598.79 Bn | 17.30 Bn | 16.91 Bn |
| 3 | AbbVie | 518.29 Bn | 486.30 Bn | 13.12 Bn | 10.77 Bn |
| 4 | Merck | 365.98 Bn | 328.92 Bn | 13.19 Bn | 9.55 Bn |
| 5 | Novartis Ag | 316.85 Bn | 290.09 Bn | - | 400.00 Mn |
| 6 | Astrazeneca | 293.40 Bn | 267.29 Bn | 13.26 Bn | 7.94 Bn |
| 7 | Amgen | 251.78 Bn | 203.43 Bn | 7.58 Bn | 13.19 Bn |
| 8 | Gilead Sciences | 210.61 Bn | 185.71 Bn | 6.73 Bn | 6.44 Bn |
| 9 | Pfizer | 166.87 Bn | 114.23 Bn | 12.56 Bn | 1.82 Bn |
| 10 | Radnostix | 20.37 Mn | 14.48 Mn | 1.36 Mn | 1.20 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.20 Mn |
| Mar 31, 2026 | 1.35 Mn |
| Dec 31, 2025 | 1.70 Mn |
| Sep 30, 2025 | 1.65 Mn |
| Jun 30, 2025 | 1.86 Mn |
| Mar 31, 2025 | 1.65 Mn |
| Dec 31, 2024 | 1.95 Mn |
| Sep 30, 2024 | 2.37 Mn |
| Jun 30, 2024 | 2.19 Mn |
| Mar 31, 2024 | 2.37 Mn |
| Dec 31, 2023 | 2.69 Mn |
| Sep 30, 2023 | 2.90 Mn |
| Jun 30, 2023 | 3.27 Mn |
| Mar 31, 2023 | 3.28 Mn |
| Dec 31, 2022 | 2.38 Mn |
| Sep 30, 2022 | 2.99 Mn |
| Jun 30, 2022 | 3.03 Mn |
| Mar 31, 2022 | 3.14 Mn |
| Dec 31, 2021 | 474,851.00 |
| Sep 30, 2021 | 753,526.00 |
API Access
Radnostix Cash & Equivalents API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=INIS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-equivalents", "ticker": "INIS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=INIS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();